Molecular Partners said it expanded an agreement with Orano Med to develop and market Radio-DARPin therapeutics for the treatment of cancer.
Earlier this month Sanofi revealed talks were ongoing with CD&R, and has now confirmed the negotiations could result in the ...
Sanofi and CD&R have entered exclusive negotiations for CD&R to acquire a 50% controlling stake in Opella, Sanofi’s consumer ...